Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic

We would like to bring to your attention the publication of the “guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic”.

The European Medicines Agency, Good Clinical Practice (GCP) Inspectors Working Group, the Clinical Trials Facilitation and Coordination Group (CTFG, a working group of the Heads of Medicines Agency (HMA)), the Clinical Trials Expert Group (CTEG, a working group of the European Commission representing Ethics Committees and National Competent Authorities) and the European Commission (EC) acknowledge the impact of COVID-19 on the health system and broader society, and the impact it may have on clinical trials and trial participants. Extraordinary measures may need to be implemented and trials adjusted due to e.g. trial participants being in self-isolation/quarantine, limited access to public places (including hospitals) due to the risk of spreading infections, and health care professionals being committed to critical tasks. Therefore, EMA, EC and HMA strongly support the efforts of the GCP Inspectors’ Working Group for developing a harmonised EU/EEA-level guidance to mitigate the negative effects of the COVID-19 pandemic on the conduct of clinical trials.

The situation is evolving, and pragmatic actions may be required to deal with the challenges of conducting research, and in ensuring the rights, safety and wellbeing of participants. The points mentioned below are intended to provide guidance for all parties involved in clinical trials during this time.

Due to the urgency, this guidance is issued without prior public consultation. The sponsors should note that due to the rapidly evolving situation further updates to this guidance are possible and likely.


COVID-19: EJEM articles published ahead of print!

Sharing information on Covid-19 is extremely important right now. That's why we would like to share these articles from the Published Ahead of Print page of the European Journal of Emergency Medicine, 

COVID-19: emergency medicine perspectives from Hong Kong
Hung, Kevin K.C.; Walline, Joseph H.; Graham, Colin A.

COVID-19: response plan for International Medical Assistance companies

François-Xavier Duchateau, Geoffrey Ramin and Anne Lepetit

COVID-19: one threat, one world, one response (magical thinking)
Òscar Miró 

How emergency departments prepare for virus disease outbreaks like COVID-19
Martin Möckel, Ulrike Bachmann, Wilhelm Behringer,Frieder Pfäfflin and Miriam Songa Stegemann

COVID-19, a UK perspective
Joanna Sriskandar and Benjamin Bloom